A carregar...
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
This study investigated the activity of lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia (CLL). Lenalidomide was given at 10 mg daily with dose escalation up to 25 mg daily. Three patients (7%) achieved a complete response (CR), one a nodular partial remission, and 10 p...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society of Hematology
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4082321/ https://ncbi.nlm.nih.gov/pubmed/18334676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-12-130120 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|